Mediflorence Medicaments Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Mediflorence Medicaments Limited

Mediflorence Medicaments Limited, a active public limited company, was established on 09 February 2012 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100DL2012PLC231292. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Sunil Kumar Sharma (Director), Vibhu Sharma (Director), Nishant Agrawal (Director). Past directors included Vibhu Sharma, Shivali Sharma, Sukhvinder Singh. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-86, R Block, Dilshad Garden, New Delhi, Delhi, 110095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2012PLC231292

  • Registration Number

    231292

  • Incorporation Date

    09 February 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 14 Year, 23 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.00 M
  • Revenue Growth **** -14.61%
  • Profit Growth **** 59.74%
  • Ebitda **** 2.93%
  • Net Worth 10.70%
  • Total Assets **** 2.92%
Company report

Mediflorence Medicaments Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mediflorence Medicaments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mediflorence Medicaments Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Kumar Sharma Director 09 Feb 2012 Current
Vibhu Sharma Director 15 Mar 2021 Current
Nishant Agrawal Director 30 Sep 2013 Current
Bijender Kumar Jain Director 09 Feb 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 15 Nov 2021 Past
Pramod Abcsdd Director 15 Mar 2021 Past
Pramod Abcsdd Whole-Time Director 15 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mediflorence Medicaments.

Mediflorence Medicaments Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 14.61% decrease. The company also saw a substantial improvement in profitability, with a 59.74% increase in profit. The company's net worth Soared by an impressive increase of 10.7%.

Mediflorence Medicaments revenue growth over time
Mediflorence Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -14.61%
*******
*******
*******
*******
Revenue from Operations
*******
 -14.61%
*******
*******
*******
*******
Total Assets
*******
 2.92%
*******
*******
*******
*******
Profit or Loss
*******
 59.74%
*******
*******
*******
*******
Net Worth
*******
 10.70%
*******
*******
*******
*******
EBITDA
*******
 2.93%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mediflorence Medicaments?

In 2021, Mediflorence Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
08 Nov 2017 Others ₹2.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Mediflorence Medicaments?

Unlock and access historical data on people associated with Mediflorence Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mediflorence Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediflorence Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mediflorence Medicaments
Recent Activity within the Organization
  • Annual General Meeting

    Mediflorence Medicaments Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Mediflorence Medicaments Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was documented.

  • Director Appointment

    Progress on Vibhu Sharma was appointed as a Director was appointed as a Director on 15 Mar 2021 & has been associated with this company since 4 years 11 months . was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.00 M with Charge ID 100147793 was registered on 08 Nov 2017. was documented.

  • Director Appointment

    The activity Nishant Agrawal was appointed as a Director was appointed as a Director on 30 Sep 2013 & has been associated with this company since 12 years 5 months . was completed.

  • Director Appointment

    Sunil Kumar Sharma was appointed as a Director was appointed as a Director on 09 Feb 2012 & has been associated with this company since 14 years 23 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mediflorence Medicaments Limited?

The CIN of Mediflorence Medicaments Limited is U24100DL2012PLC231292.

Where is Mediflorence Medicaments Limited headquartered?

Mediflorence Medicaments Limited is headquartered at B-86, R Block, Dilshad Garden, New Delhi, Delhi, 110095.

When was Mediflorence Medicaments Limited incorporated?

Mediflorence Medicaments Limited was incorporated on 09 February 2012.

Who are the current directors of Mediflorence Medicaments Limited?

The current directors of Mediflorence Medicaments Limited are

What is the primary industry of Mediflorence Medicaments Limited?

The primary industry of Mediflorence Medicaments Limited is Trade.

Is Mediflorence Medicaments Limited a listed company?

Mediflorence Medicaments Limited is unlisted.

What is the capital structure of Mediflorence Medicaments Limited?

The authorized capital of Mediflorence Medicaments Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Mediflorence Medicaments Limited?

The compliance status of Mediflorence Medicaments Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available